Bioorganic and Medicinal Chemistry p. 5766 - 5779 (2018)
Update date:2022-08-17
Topics:
Harper, Angelica R.
Le, Anh T.
Mather, Timothy
Burgett, Anthony
Berry, William
Summers, Jody A.
The retinaldehyde dehydrogenase (RALDH) enzymes, RALDH1, RALDH2, and RALDH3, catalyze the irreversible oxidation of retinaldehyde to all-trans-retinoic acid (ATRA). Despite the importance of the RALDH enzymes in embryonic development, postnatal growth and differentiation, and in several disease states, there are no commercially available inhibitors that specifically target these isozymes. We report here the development and characterization of a small molecule inhibitor dichloro-all-trans-retinone (DAR) (Summers et al., 2017) that is an irreversible inhibitor of RALDH1, 2, and 3 that effectively inhibits RALDH1, 2, and 3 in the nanomolar range but has no inhibitory activity against mitochondrial ALDH2. These results provide support for the development of DAR as a specific ATRA synthesis inhibitor for a variety of experimental and clinical applications.
View Moreshanghai jinshan pharmaceutical Co.,Ltd
Contact:021-57363011,13681638167
Address:No. 7966 Tingfeng Road,Jinshan,Shanghai,China
Contact:86-10-62983737; +86-10-51287608
Address:4/F Building C, 2 Shangdi Xinxi Road
Contact:+86-15995924277
Address:WuZhongOu suzhou new south road 89
Chiral Quest (Suzhou) Company Ltd
website:http://www.chiralquest.com
Contact:+86-0512-62956066
Address:B1/9, 218 Xinghu Street, Suzhou Industrial Park
Liaoning Yufeng Chemical Co.,Ltd.
Contact:86-0419-3418888
Address:The metallurgical industrial zone,shoushan town, Liaoyang, Liaoning, China
Doi:10.1021/jm0100281
(2002)Doi:10.1002/ejoc.201500460
(2015)Doi:10.1021/ja01226a513
()Doi:10.1016/j.bmcl.2013.11.015
(2014)Doi:10.1021/jp013955s
(2002)Doi:10.1021/jp982103y
(1998)